202 related articles for article (PubMed ID: 37780447)
21. Vulvar Cancer Incidence in the United States and its Relationship to Human Papillomavirus Vaccinations, 2001-2018.
Berenson AB; Chang M; Hawk ET; Ramondetta LM; Hoang T
Cancer Prev Res (Phila); 2022 Nov; 15(11):777-784. PubMed ID: 35969832
[TBL] [Abstract][Full Text] [Related]
22. HPV in genital cancers (at the exception of cervical cancer) and anal cancers.
de Sanjosé S; Bruni L; Alemany L
Presse Med; 2014 Dec; 43(12 Pt 2):e423-8. PubMed ID: 25455637
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus-related anogenital premalignancies and cancer in renal transplant recipients: A Danish nationwide, registry-based cohort study.
Reinholdt K; Thomsen LT; Dehlendorff C; Larsen HK; Sørensen SS; Haedersdal M; Kjaer SK
Int J Cancer; 2020 May; 146(9):2413-2422. PubMed ID: 31291470
[TBL] [Abstract][Full Text] [Related]
24. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
Gilbert DC; Wakeham K; Langley RE; Vale CL
Br J Cancer; 2019 Jan; 120(2):256-268. PubMed ID: 30482913
[TBL] [Abstract][Full Text] [Related]
25. HPV16 variants distribution in invasive cancers of the cervix, vulva, vagina, penis, and anus.
Nicolás-Párraga S; Gandini C; Pimenoff VN; Alemany L; de Sanjosé S; Xavier Bosch F; Bravo IG;
Cancer Med; 2016 Oct; 5(10):2909-2919. PubMed ID: 27654117
[TBL] [Abstract][Full Text] [Related]
26. The evolution of HPV-related anogenital cancers reported in Quebec - incidence rates and survival probabilities.
Louchini R; Goggin P; Steben M
Chronic Dis Can; 2008; 28(3):99-106. PubMed ID: 18341764
[TBL] [Abstract][Full Text] [Related]
27. The burden of human papillomavirus infections and related diseases in sub-saharan Africa.
De Vuyst H; Alemany L; Lacey C; Chibwesha CJ; Sahasrabuddhe V; Banura C; Denny L; Parham GP
Vaccine; 2013 Dec; 31 Suppl 5(0 5):F32-46. PubMed ID: 24331746
[TBL] [Abstract][Full Text] [Related]
28. Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea.
Choi I; Lee D; Son KB; Bae S
BMC Public Health; 2020 Jun; 20(1):1035. PubMed ID: 32600300
[TBL] [Abstract][Full Text] [Related]
29. Five-year relative survival for human papillomavirus-associated cancer sites.
Razzaghi H; Saraiya M; Thompson TD; Henley SJ; Viens L; Wilson R
Cancer; 2018 Jan; 124(1):203-211. PubMed ID: 29105738
[TBL] [Abstract][Full Text] [Related]
30. Assessing the annual economic burden of preventing and treating anogenital human papillomavirus-related disease in the US: analytic framework and review of the literature.
Insinga RP; Dasbach EJ; Elbasha EH
Pharmacoeconomics; 2005; 23(11):1107-22. PubMed ID: 16277547
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana.
Rantshabeng PS; Moyo S; Moraka NO; Ndlovu A; MacLeod IJ; Gaseitsiwe S; Kasvosve I
BMC Infect Dis; 2017 Nov; 17(1):731. PubMed ID: 29178840
[TBL] [Abstract][Full Text] [Related]
32. [Baseline Incidence of HPV-Associated Invasive and in Situ Cancers in Germany Prior to Potential Vaccination Effects].
Sophia Rudolph CE; Katalinic A
Gesundheitswesen; 2019 Dec; 81(12):993-1000. PubMed ID: 29933495
[TBL] [Abstract][Full Text] [Related]
33. [Human papillomavirus and the risk of anogenital cancer].
Melbye M; Svare EI; Kjaer SK; Frisch M
Ugeskr Laeger; 2002 Dec; 164(50):5950-3. PubMed ID: 12553119
[TBL] [Abstract][Full Text] [Related]
34. The role of circulating viral and tumour DNA in the diagnosis and management of HPV associated anogenital cancers, a systematic review and meta-analysis.
Elasifer H; Amukwaya MMN; Bhatia R; Cuschieri K; Gregory JM
J Clin Virol; 2023 Jul; 164():105469. PubMed ID: 37163963
[TBL] [Abstract][Full Text] [Related]
35. [Analysis on cancer incidence and mortality attributed to human papillomavirus infection in China, 2016].
Yuan MW; Wang HH; Duan RF; Xu KP; Hu SY; Qiao YL; Zhang Y; Zhao F
Zhonghua Liu Xing Bing Xue Za Zhi; 2022 May; 43(5):702-708. PubMed ID: 35589576
[No Abstract] [Full Text] [Related]
36. Incidence, Trends and Ethnic Differences of Oropharyngeal, Anal and Cervical Cancers: Singapore, 1968-2012.
Lam JO; Lim WY; Chow KY; D'Souza G
PLoS One; 2015; 10(12):e0146185. PubMed ID: 26720001
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive control of human papillomavirus infections and related diseases.
Bosch FX; Broker TR; Forman D; Moscicki AB; Gillison ML; Doorbar J; Stern PL; Stanley M; Arbyn M; Poljak M; Cuzick J; Castle PE; Schiller JT; Markowitz LE; Fisher WA; Canfell K; Denny LA; Franco EL; Steben M; Kane MA; Schiffman M; Meijer CJ; Sankaranarayanan R; Castellsagué X; Kim JJ; Brotons M; Alemany L; Albero G; Diaz M; de Sanjosé S;
Vaccine; 2013 Nov; 31 Suppl 8(0 8):I1-31. PubMed ID: 24229716
[TBL] [Abstract][Full Text] [Related]
38. Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis.
Matsuo K; Blake EA; Machida H; Mandelbaum RS; Roman LD; Wright JD
Gynecol Oncol; 2018 Sep; 150(3):501-508. PubMed ID: 30054103
[TBL] [Abstract][Full Text] [Related]
39. Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007.
Kurdgelashvili G; Dores GM; Srour SA; Chaturvedi AK; Huycke MM; Devesa SS
Cancer; 2013 Jun; 119(12):2291-9. PubMed ID: 23580435
[TBL] [Abstract][Full Text] [Related]
40. Relationship between human papillomavirus infection and tumours of anogenital sites other than the cervix.
Daling JR; Sherman KJ
IARC Sci Publ; 1992; (119):223-41. PubMed ID: 1330912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
